TRAF6 and atherosclerosis: Recently, we have developed small molecule inhibitors of the CD40–TRAF6 interaction, TRAF‐STOPs, and we were able to show that these small molecule inhibitors can reduce atherosclerosis, peritonitis, sepsis and metabolic complications of diet‐induced obesity in mice 23, 28, 29.